DLI Del Laboratories

Del Laboratories Named Most Innovative Marketer of the Year By Women's Wear Daily - Company Recognized For 'Continuous Flow of Innovation' In Its Cosmetics Brands - UNIONDALE, N.Y., Dec. 10 /PRNewswire-FirstCall/ -- Del Laboratories, Inc. today announced that it has been named most innovative marketer of the year among companies in Women's Wear Daily's ("WWD Beauty Biz") most recent "2003 Awards Issue." WWD notes that this distinction recognizes the Company's cosmetics brands' "continuous flow of innovation across product categories." Commenting on the honor, Dan K. Wassong, Chairman, President and Chief Executive Officer of Del Laboratories said, "We are delighted that our Company continues to be recognized by industry observers and our customers for our Company's dedication to product innovation, brand excellence and focus. From our market preeminence throughout the nail care and nail color categories under our renowned Sally Hansen brand, to our broad range of innovative new cosmetics products such as NYC New York Color, Del continues to demonstrate its leadership across its markets in building its brands and in delivering value to customers and shareholders alike." Mr. Wassong concluded, "Proud as we are of what we have achieved, recognition such as this only reinforces our constant pursuit of excellence in all that we do. Going forward, we will continue to emphasize product innovation and more across both our cosmetics and over-the-counter pharmaceutical businesses." Del Laboratories, Inc., markets and manufactures cosmetics and over the counter pharmaceuticals. Its major brands include SALLY HANSEN HARD AS NAILS(R), America's number one nail protection, CORNSILK(R) face makeup, LACROSS(R) nail and beauty implements, lip color, skin care, bleaches and depilatories, all under the SALLY HANSEN brand franchise, NATURISTICS(R) cosmetics, and N.Y.C. New York Color(TM) cosmetics. The Company's Del Pharmaceuticals subsidiary includes ORAJEL(R), the number one brand of topical oral analgesics, ARTHRICARE(R), PRONTO(R), DERMAREST(R) PSORIASIS, AURO-DRI(R), TANAC(R) and PROPA pH(R). DATASOURCE: Del Laboratories, Inc. CONTACT: Enzo J. Vialardi, Executive Vice President and Chief Financial Officer of Del Laboratories, Inc., +1-516-844-2050 Web site: http://www.dellabs.com/

Copyright